2015 Strategies in the French Hospital Infectious Disease Testing Market
This new report from VPGMarketResearch.com contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including:
- Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms.
- Volume and sales forecasts for 80 infectious disease tests performed in French hospital laboratories.
- Instrumentation technologies and feature comparison of leading analyzers.
- Sales and market shares of leading suppliers by test.
- Emerging diagnostic technologies and their potential market applications.
- Product development opportunities.
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for suppliers.
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Infectious Disease Tests
1. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. INFLUENZA VIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. LEGIONELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. MONONUCLEOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. MYCOPLASMA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. PNEUMONIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. RESPIRATORY SYNCYTIAL VIRUS (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. TUBERCULOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Infectious Disease Tests
1. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. INFLUENZA VIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. LEGIONELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. MONONUCLEOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. MYCOPLASMA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. PNEUMONIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. RESPIRATORY SYNCYTIAL VIRUS (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. TUBERCULOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
LIST OF TABLES
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests
France Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Adenovirus Testing Market Diagnostics Sales by Major Supplier
France Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
France Influenza Testing Market Diagnostics Sales by Major Supplier
France Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
France Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Mononucleosis Testing Market Diagnostics Sales by Major Supplier
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
France Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
France RSV Test Volume and Diagnostics Sales Forecast by Market Segment
France RSV Testing Market Diagnostics Sales by Major Supplier
France Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests
France Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Adenovirus Testing Market Diagnostics Sales by Major Supplier
France Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
France Influenza Testing Market Diagnostics Sales by Major Supplier
France Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
France Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Mononucleosis Testing Market Diagnostics Sales by Major Supplier
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
France Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
France RSV Test Volume and Diagnostics Sales Forecast by Market Segment
France RSV Testing Market Diagnostics Sales by Major Supplier
France Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier